Harmony Biosciences Holdings (HRMY) Non-Current Debt: 2019-2025
Historic Non-Current Debt for Harmony Biosciences Holdings (HRMY) over the last 5 years, with Sep 2025 value amounting to $148.5 million.
- Harmony Biosciences Holdings' Non-Current Debt fell 11.52% to $148.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $148.5 million, marking a year-over-year decrease of 11.52%. This contributed to the annual value of $163.0 million for FY2024, which is 8.71% down from last year.
- Harmony Biosciences Holdings' Non-Current Debt amounted to $148.5 million in Q3 2025, which was down 3.16% from $153.3 million recorded in Q2 2025.
- Harmony Biosciences Holdings' Non-Current Debt's 5-year high stood at $195.6 million during Q2 2021, with a 5-year trough of $148.5 million in Q3 2025.
- Its 3-year average for Non-Current Debt is $169.4 million, with a median of $171.4 million in 2024.
- Data for Harmony Biosciences Holdings' Non-Current Debt shows a maximum YoY fell of 11.52% (in 2025) over the last 5 years.
- Over the past 5 years, Harmony Biosciences Holdings' Non-Current Debt (Quarterly) stood at $190.0 million in 2021, then dropped by 0.18% to $189.6 million in 2022, then fell by 5.84% to $178.6 million in 2023, then declined by 8.71% to $163.0 million in 2024, then dropped by 11.52% to $148.5 million in 2025.
- Its Non-Current Debt was $148.5 million in Q3 2025, compared to $153.3 million in Q2 2025 and $158.2 million in Q1 2025.